Wiley

Cardiovascular Drug Reviews Template

Write in a clean editor, then format for Cardiovascular Drug Reviews in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Cardiovascular Drug Reviews format

Cardiovascular Drug Reviews is a peer-reviewed journal published by Wiley, covering Cardiac electrophysiology and arrhythmias, Receptor Mechanisms and Signaling, Ion channel regulation and function.

PublisherWiley
Reference styleAuthor–year (Chicago)
Author–year — (Smith, 2023) in the text
Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Cardiovascular Drug Reviews 12 (3): 45–58.

Formats any DOI in Cardiovascular Drug Reviews style. No sign-up.

Publishes research inCardiac electrophysiology and arrhythmias Receptor Mechanisms and Signaling Ion channel regulation and function Analytical Methods in Pharmaceuticals Nitric Oxide and Endothelin Effects
ISSN0897-5957
h-index61
i10-index256
Total citations14,213
Top institutions publishing hereYale University
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Cardiovascular Drug Reviews per year

33
1999
31
2000
31
2001
33
2002
29
2003
30
2004
10
2005
46
2006
38
2007
11
2008
1
2010
1
2015

Citation impact of Cardiovascular Drug Reviews by publication year

510
1999
409
2000
1.3K
2001
1.2K
2002
755
2003
1.5K
2004
246
2005
2.5K
2006
1.9K
2007
332
2008
6
2010
0
2015

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Cardiovascular Drug Reviews

Cardiovascular Protective Effects of Resveratrol

Silvia Bradamante, Livia Barenghi, Alessandro Villa · 1 Sep 2004

Resveratrol (3,4',5-trihydroxy-trans-stilbene), a phytoalexin found in grape skins, peanuts, and red wine, has been reported to have a wide range of biological and pharmacological properties. It has been speculated that at low doses (such as consumed in the common diet) resveratrol may have cardioprotective activity. In this article we describe recent in vitro and in…

Role of Poly(ADP‐ribose) polymerase 1 (PARP‐1) in Cardiovascular Diseases: The Therapeutic Potential of PARP Inhibitors

Pál Pacher, Csaba Szabó · 1 Sep 2007

Accumulating evidence suggests that the reactive oxygen and nitrogen species are generated in cardiomyocytes and endothelial cells during myocardial ischemia/reperfusion injury, various forms of heart failure or cardiomyopathies, circulatory shock, cardiovascular aging, diabetic complications, myocardial hypertrophy, atherosclerosis, and vascular remodeling following injury. These reactive species induce oxidative DNA damage and consequent activation of the nuclear…

The Many Faces of H89: A Review

Amanda Lochner, Johan A. Moolman · 1 Sep 2006

H89 is marketed as a selective and potent inhibitor of protein kinase A (PKA). Since its discovery, it has been used extensively for evaluation of the role of PKA in the heart, osteoblasts, hepatocytes, smooth muscle cells, neuronal tissue, epithelial cells, etc. Despite the frequent use of H89, its mode of specific inhibition of PKA…

Olprinone: A Phosphodiesterase III Inhibitor with Positive Inotropic and Vasodilator Effects

Katsufumi Mizushige, Takashi Ueda, Kazushi Yukiiri et al. · 1 Sep 2002

Olprinone is a newly developed phosphodiesterase III inhibitor characterized by several properties. First, olprinone has positive inotropic and vasodilator actions and improves myocardial mechanical efficiency. Second, olprinone augments cerebral blood flow by a direct vasodilatory effect on cerebral arteries. The cerebrovascular reactivity to olprinone is marked in patients with impaired cerebral circulation. Third, olprinone selectively…

Cardiovascular Actions of Berberine

Chi‐Wai Lau, Xiaoqiang Yao, Zhen‐Yu Chen et al. · 1 Sep 2001

Berberine, is an alkaloid from Hydrastis canadensis L., Chinese herb Huanglian, and many other plants. It is widely used in traditional Chinese medicine as an antimicrobial in the treatment of dysentery and infectious diarrhea. This manuscript describes cardiovascular effects of berberine and its derivatives, tetrahydroberberine and 8-oxoberberine. Berberine has positive inotropic, negative chronotropic, antiarrhythmic, and…

Cardiovascular Drug Reviews template — frequently asked questions

How do I write a paper in the Cardiovascular Drug Reviews format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Cardiovascular Drug Reviews template. When you export, DocuGuru compiles the paper into the official Wiley format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Cardiovascular Drug Reviews use?
Cardiovascular Drug Reviews uses Author–year (Chicago) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Cardiovascular Drug Reviews 12 (3): 45–58.
Do I need to know LaTeX to submit to Cardiovascular Drug Reviews?
No. DocuGuru generates the USG LaTeX class and compiles the PDF for you in the background, so you get a Wiley-ready Cardiovascular Drug Reviews document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Cardiovascular Drug Reviews template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Cardiovascular Drug Reviews format with correct headings, figures, tables, and author–year citations.
Who publishes Cardiovascular Drug Reviews?
Cardiovascular Drug Reviews is a multidisciplinary journal published by Wiley. DocuGuru's Cardiovascular Drug Reviews template matches Wiley's official submission format.
Can I export a submission-ready Cardiovascular Drug Reviews PDF?
Yes — DocuGuru produces a PDF built with the official Cardiovascular Drug Reviews template (the USG class) that is ready to submit to Wiley, together with the matching LaTeX source files.
How much does the Cardiovascular Drug Reviews template cost?
You can start writing in the Cardiovascular Drug Reviews template for free. Exporting the final submission-ready Cardiovascular Drug Reviews PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Cardiovascular Drug Reviews template